Patents by Inventor Zsolt Szekelyhidi

Zsolt Szekelyhidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
    Patent number: 8802849
    Abstract: The invention relates to novel tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, as well as their pharmaceutically acceptable salts. The subject of the invention too the process for producing the compounds and their use as a pharmaceutically active agent and as pharmaceutical compositions for prophylaxis and/or treatment of proliferative diseases such as cancer.
    Type: Grant
    Filed: February 19, 2008
    Date of Patent: August 12, 2014
    Assignee: Vichem Chemie Kutató Kft.
    Inventors: Péter Bánhegyi, György Kéri, Lászlö Örfi, Zsolt Szekélyhidi, Frigyes Wáczek
  • TRICYCLIC BENZO[4,5]THIENO-[2,3-D]PYRIMIDINE-4-YL-AMIN DERIVATIVES, THEIR SALTS, PROCESS FOR PRODUCING THE COMPOUNDS AND THEIR PHARMACEUTICAL USE
    Publication number: 20110015214
    Abstract: The invention relates to novel tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, as well as their pharmaceutically acceptable salts. The subject of the invention too the process for producing the compounds and their use as a pharmaceutically active agent and as pharmaceutical compositions for prophylaxis and/or treatment of proliferative diseases such as cancer.
    Type: Application
    Filed: February 19, 2008
    Publication date: January 20, 2011
    Inventors: Pèter Bánhegyi, Kéri György, Lászlõ Örfi, Zsolt Szekélyhidi, Frigyes Wáczek
  • Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
    Publication number: 20090298842
    Abstract: Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases.
    Type: Application
    Filed: August 1, 2009
    Publication date: December 3, 2009
    Inventors: János Pató, György Kéri, László Örfi, Frigyes Wáczek, Zoltán Horváth, Péter Banhegyi, Istaván Szabadkai, Jenö Marosfalvi, Bálint Hegymegi-barakonyi, Zsolt Székélyhidi, Zoltán Greff, Axel Choidas, Gerald Bacher, Andrea Missio, Anil Koul
  • Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
    Publication number: 20040171603
    Abstract: Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases.
    Type: Application
    Filed: November 18, 2003
    Publication date: September 2, 2004
    Inventors: Janos Pato, Gyorgy Keri, Laszlo Orfi, Frigyes Waczek, Zoltan Horvath, Peter Banhegyi, Istavan Szabadkai, Jeno Marosfalvi, Balint Hegymegi-Barakonyi, Zsolt Szekelyhidi, Zoltan Greff, Axel Choidas, Gerald Bacher, Andrea Missio, Anil Koul